BUSINESS REGISTRATION NUMBER
BRN 62736724
LiveLicensed Chinese Medicine Dealer · PW-2022-00188Licensed Drug Dealer · 30/2A/2020

NeoPharm Limited

創健藥業有限公司

Registry Verified: 2026-09-20
Jurisdiction: Hong Kong, ChinaJurisdiction: Hong Kong

NeoPharm Limited (創健藥業有限公司) is a Hong Kong corporation duly incorporated under the Companies Ordinance (Cap. 622), legally classified as a Private company limited by shares. Its official Company Registration Number (CR No. / CRN) is 2036381, and Business Registration Number (BRN) is 62736724. Incorporated on 2014-02-13, the entity has maintained continuous statutory operations for 12 years, currently holding an active legal status of Live. In terms of statutory licensing, the corporation is officially authorized and regulated in Hong Kong, holding Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2022-00188), Department of Health (DH Licensed Dealer) (Licence No. 30/2A/2020). The registered office is situated at ROOM B2, 3/F, F., WONG KING INDUSTRIAL BUILDING, 2 TAI YAU STREET, SAN PO KONG, HONG KONG.

I. Corporate Profile & Chinese Medicine Regulatory Office Licensed Trader Statutory Licensing Status (CMRO Licence: PW-2022-00188)

Official Chinese Name 創健藥業有限公司 Official English Name NeoPharm Limited
Company Reg No. (CRN) 2036381 Business Reg No. (BRN) 62736724
Incorporation Date 2014-02-13 Company Category Private company limited by shares
Current Legal Status Live Statutory Filing Cycle
2027-02-13✓ 2026 Return Filed
Registered Office Address
ROOM B2, 3/F, F., WONG KING INDUSTRIAL BUILDING, 2 TAI YAU STREET, SAN PO KONG, HONG KONGWong King Industrial Building · View Co-Located Entities →
Significant Controllers (SCR) Statutorily maintained. To penetrate ultimate beneficial owners (UBO) and holding structures, please apply for a Due Diligence Report.

II. Licensed Chinese Medicine Trader Document Retrieval (Annual Return NAR1 / Articles / ND2A / CTC)

#Filing DateDocument No.Document NamePagesTariffAction
1 2026-03-20 22602761660
NAR1Annual Return (2026) (English)
2026-03-20·22602761660·9p·HK$ 28
9 HK$ 28
2 2025-10-31 24001962407
ND2ANotice of Change of Company Secretary and Director (English)
2025-10-31·24001962407·3p·HK$ 20
3 HK$ 20
3 2025-04-02 24001799431
ND4Notice of Resignation of Company Secretary and Director (English)
2025-04-02·24001799431·2p·HK$ 20
2 HK$ 20
4 2025-02-18 22802797963
NAR1Annual Return (2025) (English)
2025-02-18·22802797963·9p·HK$ 28
9 HK$ 28
5 2024-02-19 23601967446
NAR1Annual Return (2024) (English)
2024-02-19·23601967446·8p·HK$ 28
8 HK$ 28
6 2023-12-27 SH000547523
BRN_REFReference Document for Business Registration Number as UBI
2023-12-27·SH000547523·1p·HK$ 20
1 HK$ 20
7 2023-02-20 22402078338
NAR1Annual Return (2023) (English)
2023-02-20·22402078338·8p·HK$ 28
8 HK$ 28
8 2022-03-03 23202149674
NAR1Annual Return (2022) (English)
2022-03-03·23202149674·8p·HK$ 28
8 HK$ 28
9 2021-02-26 23002022364
NAR1Annual Return (2021) (English)
2021-02-26·23002022364·8p·HK$ 28
8 HK$ 28
10 2020-04-27 24000984141
NR2Notice of Location of Registers and Company Records (English)
2020-04-27·24000984141·2p·HK$ 20
2 HK$ 20

III. Commercial Due Diligence & Licensed Chinese Medicine Trader Responsible Person & Proprietary Medicine Compliance

Statutory Licences (32 Regulators) Licensed Entity
Chinese Medicine Regulatory Office (CMRO)
Active (Licensed)
Licence No. PW-2022-00188
Department of Health (DH Licensed Dealer)
Active (Licensed)
Licence No. 30/2A/2020
Court Litigation & Insolvency No Court Records
Screened against 1M+ corporate litigation records; no public court cases or winding-up petitions (HCCW) found.
Regulatory Disciplinary & Alert Lists Clean Record
Screen official gazettes, HKMA alert lists, TCSP disciplinary notices, SFC enforcement actions, and customs compliance lists. No negative enforcement records found.
Office & Address Verification Address Resolved
ROOM B2, 3/F, F., WONG KING INDUSTRIAL BUILDING, 2 TAI YAU STREET, SAN PO KONG, HONG KONG
Statutory Office under Cap. 622 Need Registered Office & Secretary? →
Hong Kong Corporate Due Diligence & Risk Screening Service
💡 Corporate management: For statutory annual return filings, registered office, or SCR compliance, explore HC BUSINESS LIMITED (TCSP TC006431). Learn More →

IV. Licensed Chinese Medicine Trader Compliance & Statutory Licensing FAQ

In statutory due diligence and corporate verification, NeoPharm Limited is authenticated as a lawful company limited by shares established on 2014-02-13 (duration: 12 years). The official gazette and registry gazette index classify its current standing as [Live / In Operation] with active business status (Last verified: September 2026).

The statutory identifiers for this corporation issued by Hong Kong SAR authorities are: 1. Business Registration Number (BRN / Unique Business Identifier UBI): [62736724] (effective from 27 December 2023, this 8-digit number serves as the official cross-departmental primary identifier and tax ID); 2. Company Registration Number (CRN): [2036381] (historical archive number issued by Companies Registry). In international banking KYC, trade bills of lading, and cross-border contracts, these two numbers uniquely confirm entity legitimacy.

Under Hong Kong law, incorporated companies do not maintain a 'legal representative' position; the Board of Directors exercises supreme statutory management authority. Under the New Inspection Regime of the Companies Ordinance, public inspection protects directors' personal identification by displaying correspondence addresses and masked ID numbers. To inspect certified directorship history, shareholding structure (Form NAR1), Significant Controllers Register (SCR), and multi-tier beneficial ownership (UBO), formal certified registers must be retrieved through statutory registry inspection or corporate due diligence procedures.

Yes. In Hong Kong corporate registration records, NeoPharm Limited has officially logged 17 statutory image filing(s) since incorporation. Key authenticated filings include the latest Annual Return (Form NAR1 - recording verified capital allocation, registered address, and director registers), original Incorporation documents (NNC1), and constitutional records, all authenticated with official ICRIS / e-Registry electronic barcodes.

According to multi-dimensional checks across Hong Kong statutory authorities: 1. Regulatory Licences: Officially licensed by Hong Kong statutory authorities, currently holding: Chinese Medicine Regulatory Office (CMRO) (Licence No. PW-2022-00188); Department of Health (DH Licensed Dealer) (Licence No. 30/2A/2020); 2. Judicial Screening (Litigation & Winding-Up): cross-referenced with Hong Kong judicial writs database; no public court cases or compulsory winding-up petitions (HCCW) were found for this entity.

The statutory registered office (corporate headquarters on official record) of NeoPharm Limited is situated at: [ROOM B2, 3/F, F., WONG KING INDUSTRIAL BUILDING, 2 TAI YAU STREET, SAN PO KONG, HONG KONG]. Pursuant to Section 658 of the Companies Ordinance (Cap. 622) of Hong Kong, all companies registered in Hong Kong must maintain an official registered office within the Hong Kong SAR where official communications, regulatory notices, and legal court process may be lawfully served.

Pursuant to Hong Kong commercial statutes, corporations operate without statutory website filing obligations. Corporate authenticity and contractual authorization of NeoPharm Limited are verified via official Companies Registry stamped filings (Form NNC1 / NAR1) and tax records (BRN: 62736724). Due diligence on statutory registers provides the sole authoritative basis for cross-border commercial transactions.

V. Similar Trade Names & Industry Directory

Retrieve Filings